Home Newsfeeds JP Morgan Maintains Overweight on Hologic, Raises Price Target to $95

JP Morgan Maintains Overweight on Hologic, Raises Price Target to $95

JP Morgan analyst Casey Woodring maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $90 to $95.

byBenzinga Newsdesk

February 2, 2023

1 minute read

JP Morgan analyst Casey Woodring maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $90 to $95.

Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

June 2, 7:58 AM

Gainers Better Choice Company Inc. (NASDAQ: BTTR) shares rose 37% to $0.4522 in pre-market trading. Better Choice said it has selected Re:Amaze to assist in customer retention and acquisition for its Halo Brand of dog and cat food.

ASTI

Bit Digital, Inc. Announces Fiscal Year 2022 Financial Highlights; FY22 Revenue $32.3M; FY22 EPS $(1.34)

By Benzinga Newsdesk

April 28, 8:08 AM

Financial Highlights for Fiscal Year 2022Total revenue was $32.3 million for the fiscal year 2022.For the year ended December 31, 2022, we recognized revenue of $31.4 million and $0.9 million from bitcoin mining services

BTBT

Boston Properties Q4 EPS $1.86 Up From $1.55 YoY, Sales $789.82M Beat $777.96M Estimate

By Happy Mohamed

February 1, 1:13 AM

Boston Properties (NYSE:BXP) reported quarterly earnings of $1.86 per share. This is a 20 percent increase over earnings of $1.55 per share from the same period last year. The company reported quarterly sales of $789.82

BXP

Cowen & Co. Maintains Outperform on Aptiv, Raises Price Target to $134

By Benzinga Newsdesk

February 3, 9:58 AM

Cowen & Co. analyst Jeffrey Osborne maintains Aptiv (NYSE:APTV) with a Outperform and raises the price target from $122 to $134.

APTV

JP Morgan Maintains Overweight on Hologic, Raises Price Target to $95

Related Posts

Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Bit Digital, Inc. Announces Fiscal Year 2022 Financial Highlights; FY22 Revenue $32.3M; FY22 EPS $(1.34)

Boston Properties Q4 EPS $1.86 Up From $1.55 YoY, Sales $789.82M Beat $777.96M Estimate

Cowen & Co. Maintains Outperform on Aptiv, Raises Price Target to $134